Appointment of Joint Corporate Broker and Joint Financial Adviser
Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...
Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
In addition to the presentations, Medicenna’s management team will be available for one-on-one meetings with investors at both conferences. Investors interested in scheduling a meeting can contact ...